RECENT FEATURE ARTICLES
Identifying life-threatening VITT using a highly specific ELISA
Vaccine-induced immune thrombocytopenia and thrombosis has been identified as a rare side effect of the ChAdOx1 nCoV-19 adenoviral vector vaccine. Alex Stephenson-Brown explains how an ELISA from Stago can detect cases of the condition.
Cytospinning through the decades: the spinning ‘60s to the COVID era
Laboratories across the world use cytocentrifugation to present cells for microscopic analysis while maintaining their morphology. Here, Epredia gives a brief history of the Cytospin and the use of cytology samples to detect respiratory viruses.
Catching COVID: how Seegene kept pace through artificial intelligence
South Korea’s response to the pandemic has been widely praised, achieving success through rigorous preparation, rapid response for detection and appropriate containment and treatment, with almost immediate access to PCR tests.
Navigating the post-COVID world: how digital health solutions can help
As the health service responds to the various backlogs that have developed as a result of the ongoing pandemic, Chris Hudson provides a brief overview of Roche digital solutions and how they facilitate better patient care.
Tackling antimicrobial resistance: the vital role of diagnostics
In the background of COVID-19, there is another silent pandemic growing – the threat of antimicrobial resistance. In vitro diagnostics are vital in the fight against AMR, ensuring appropriate administration of antibiotics and reducing their misuse.
IBMS Congress 2022: delivering science and celebrating achievement
In March 2022, the delayed fourteenth iteration in the biennial Congress series will return to the ICC in Birmingham. The focus will be on the very best that biomedical science and commercial colleagues have to offer.
Method comparison studies: a review of the process and report
Now embarking on the final article in his series on method comparisons. Stephen MacDonald concludes with advice on preparation of the documentation and final report.
SARS-CoV-2 mutation identification: a look at the latest solutions
The detection of SARS-CoV-2 mutations and new, potentially more infectious and transmissible variants of the virus currently is exercising the minds of the scientific and commercial communities. PerkinElmer examines the various testing methodologies.
Gastrointestinal pathogens: a Cornish view and milestone in detection
Gemma Vanstone recounts how she discovered the molecular EntericBio system, and the positive impact that clinicians and patients can experience when a local pathology service works closely with Serosep and uses its range of real-time PCR tests.
South of Tyne network: coagulation expertise integral to success
Haemostasis capacity in the north-east of England has enjoyed significant benefits through collaboration with Stago UK. Here, staff from the South Tyne region explain how this collaboration has borne fruit in terms of compliance and efficiency.
Gastric cancer diagnosis: bridging the gap by biomarker assessment
Graham Johnson introduces the first non-invasive test for assessing the structure and function of the stomach in patients with dyspepsia. It can be used in the primary care setting and also in secondary care as a pre-endoscopy assessment tool.
Wolbachia: an example of natural protection against human disease
It is almost a decade since it was shown that a strain of the endosymbiont Wolbachia that infects mosquitoes can make them resistant to the malaria parasite. Wolbachia can also have an impact on dengue, Zika and other mosquito-transmitted diseases.
Point-of-care testing in a pandemic age: open-access current research
During the current SARS-CoV-2 pandemic, point-of-care testing (POCT) is proving invaluable in facilitating the easing of restrictions and a return to normality. The following examples illustrate how this technology is being applied and assessed.
New haemostasis workflow solutions offer enhanced immunology testing
The CN-3000 and CN-6000 models from Sysmex are joined by the CN-3500 and CN-6500 systems to provide laboratories with advanced immunological testing capabilities, and connectivity of these systems by the intelligent Laboratory Automation solution.
Point-of-care MRSA tests of trauma patients offer trust-wide benefits
At Torbay Hospital in Torquay, the microbiology and orthopaedic departments collaborated to implement point-of-care testing for methicillin-resistant Staphylococcus aureus to increase bed occupancy and enhance patient experience.
A look at improving patient safety: the devil is in the data
With the recent announcement about reducing bureaucracy and the publication of a consultation document, the time is ripe to look at how managing data more efficiently can have a dramatic impact on improving patient safety, as Phil Taylor explains.
Upskilling pathologists: how it can help address cancer challenges
Sheila Devaney looks at the training Roche offers pathologists using the PD-L1 tests for non-small cell lung cancer and triple-negative breast cancer, and the development of algorithms to support the diagnosis and targeted treatment of cancer.
Collaborative approach to networking at South 4 Pathology Partnership
Laboratories in Buckinghamshire, Milton Keynes, Oxfordshire and Swindon will use the CliniSys WinPath Enterprise system to deliver a consistent, high-quality and equitable service and build a platform for innovation across the pathology partnership.
Type 2 diabetes: proteins, oxidative status and stress, and biomarkers
Of the hundreds of millions of diabetes cases globally, 90% are estimated to be type 2 diabetes mellitus. Although T2DM is more common in adults, as obesity in children, teenagers and young adults has increased, so too has the incidence of T2DM.
Congress 2022: an ideal opportunity to link learning to the laboratory
In March next year, the biennial IBMS Congress will return to the International Convention Centre in Birmingham. The event will focus once again on the very best that biomedical science and commercial colleagues have to offer.
Featured Supplier
Verulam Scientific Ltd is an analytical instrument company providing innovative solutions and emerging technologies to the UK pharmaceutical, environmental, life science, food, clinical and biotechnology markets. We provide laboratories with the equipment and services that are crucial to modern analytical services and research.
Upcoming Events
Every Minute Counts: a SHOT, BBTS and NBTC joint webinar
Online
3 December 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
